Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)

NCT01129284 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT01129284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01129284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
Lead sponsor
Columbia University
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2009
Completion date
September 30, 2011
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant nephrotic syndrome